| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| USRE41134 | BAUSCH | Slow release vehicles for minimizing skin irritancy of topical compositions |
Feb, 2015
(9 years ago) | |
| US6387383 | BAUSCH | Topical low-viscosity gel composition |
Aug, 2020
(3 years ago) | |
Ziana is owned by Bausch.
Ziana contains Clindamycin Phosphate; Tretinoin.
Ziana has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Ziana are:
- USRE41134
- US6387383
Ziana was authorised for market use on 07 November, 2006.
Ziana is available in gel;topical dosage forms.
Ziana can be used as topical treatment of acne vulgaris in patients 12 years or older, topical treatment of acne vulgaris.
The generics of Ziana are possible to be released after 03 August, 2020.
Drugs and Companies using CLINDAMYCIN PHOSPHATE; TRETINOIN ingredient
Market Authorisation Date: 07 November, 2006
Treatment: Topical treatment of acne vulgaris; Topical treatment of acne vulgaris in patients 12 years or older
Dosage: GEL;TOPICAL
ZIANA family patents
